美国FDA和Roche公司强调抗疟药甲氟喹(mefloquine,Lariam)的药品说明书增加了下列内容:●甲氟喹禁用于抑郁症发作、有近期抑郁症史、广泛性焦虑症、精神病、精神分裂症病人和其它严重的精神疾患或有惊厥史的病人。●在预防用药期间如果出现精神症状,如急性焦虑、抑郁、坐立不安 The FDA and Roche emphasize the addition of the following pharmacopeia to the anti-malarial mefloquine (Lariam): ● Mefloquine is banned from depression, has a history of recent depression, generalized anxiety disorder, psychosis, schizophrenia Symptoms and other serious mental disorders or patients with a history of convulsions. ● during the preventive medication if there are mental symptoms such as acute anxiety, depression, restlessness